More distantly, about 20 HIV vaccines are currently in clinical trials, according to the New York-based AIDS Vaccine Initiative (IAVI).

FORBES: Magazine Article

Vaccines sponsored by Merck and IAVI are being fast-tracked to Phase II.

FORBES: Magazine Article

The IAVI team joined forces with the Scripps Research Institute, and the biotechnology companies Theraclone Sciences and Monogram Biosciences on the project.

BBC: Antibodies 'may aid HIV jab hunt'

The team's approach, which IAVI Vice President Wayne Koff calls very promising, makes use of a three-step process to teach the immune system to keep the HIV virus in check.

FORBES: Latest Hope For An AIDS Vaccine

Under his leadership, IAVI implemented a global advocacy program that assured that vaccines received prominent attention in the media and in forums such as the G8, EU and the UN.

FORBES: GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power

The two new ones reported by Dr Walker and Dr Phogat are the first fruits of a project called Protocol G, one of several multi-centre investigations into various aspects of AIDS that IAVI is helping to organise.

ECONOMIST: AIDS vaccines